SciSparc Ltd.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company’s operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
/ 
Frequently asked questions
To buy SciSparc Ltd. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for SciSparc Ltd. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for SciSparc Ltd. is SPRC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
SciSparc Ltd. has its primary listing on NASDAQ (Small cap). You can trade SciSparc Ltd. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, SciSparc Ltd. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include SciSparc Ltd. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like SciSparc Ltd..